Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

In recent years, the capabilities of artificial intelligence (AI) have grown exponentially, revolutionizing industries and reshaping the fabric of society.

Next-generation optical inspection is about more than just sensitivity. It’s about reliably seeing through complexity.